Article: Scandipharm Eases Financial Burden for Newly-Diagnosed CF Patient.

BIRMINGHAM, Ala., Oct. 16 /PRNewswire/ -- Scandipharm, Inc. announced plans to introduce an innovative, new program that will help ease the financial burden of infant patients diagnosed with cystic fibrosis (CF). Beginning in January 1999, the CareFirst For CF(TM) program will provide at no cost certain medications for CF patients under two years of age. Company President and CEO Thomas S. Stribling made the announcement today at the 12th Annual North American Cystic Fibrosis Conference in Montreal, Quebec, Canada.

Families of CF patients experience tremendous emotional strain and formidable issues in the early days of diagnosis. Once the emotion subsides, the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!